📰 Phasei First Time News
Phasei First Time News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phasei First Time. Real-time updates on events, politics, business and more.
December 14, 2023
/PRNewswire/ -- Mission Therapeutics ("Mission" or the "Company"), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today...
December 14, 2023
14 Dec 2023 - Mission gains clearance from US FDA for Phase II trial of MTX652 after it receives official approval of its Investigational New Drug application ...
June 29, 2022
The rising incidence of COPD and the exacerbations associated with it have been instrumental in piquing the interest of pharma players and academia in...
May 18, 2022
First non-antibiotic macrolide to go into clinical development targeting COPD Safety, tolerability and pharmacokinetic endpoints met Phase II planning underway EpiEndo Pharmaceuticals
May 18, 2022
First non-antibiotic macrolide to go into clinical development – targeting COPDSafety, tolerability and pharmacokinetic endpoints metPhase II planning underwayREYKJAVIK, Iceland, May 18, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modi...